Small Nucleic Acid Drugs are nucleic acid-based drugs, including small interfering RNA (siRNA), antisense oligonucleotides (ASO), microRNA (miRNA) and aptamers. These drugs regulate gene expression by binding to target genes or their mRNAs, with high specificity and design flexibility. They can precisely target specific genes or RNA sequences, thus providing new possibilities in treating many diseases that are considered "undruggable", such as genetic diseases, cancer and viral infections. Compared with traditional drugs, small nucleic acid drugs are developed faster because they do not require complex structural matching or a long screening process.

Despite the great potential of small nucleic acid drugs, they also face many challenges in clinical practice, mainly including stability (easily degraded by nucleases), delivery difficulties (cell membranes hinder their entry into cells) and immune responses. However, technological advances in recent years, such as chemical modification, ligand binding and the application of nanotechnology, have significantly improved these problems. Currently, several small nucleic acid drugs have been approved by the FDA for the treatment of diseases such as hereditary transthyretin-mediated amyloidosis, spinal muscular atrophy and acute hepatic porphyria. In the future, small nucleic acid drugs are expected to play a role in the treatment of more diseases, and their efficacy can be further improved by combining them or using them in conjunction with other treatments. Continuing to improve delivery strategies and reduce costs will be the key to promoting their widespread application.

Report Scope
This report aims to deliver a thorough analysis of the global market for Small Nucleic Acid Drug, offering both quantitative and qualitative insights to assist readers in formulating business growth strategies, evaluating the competitive landscape, understanding their current market position, and making well-informed decisions regarding Small Nucleic Acid Drug.

The report is enriched with qualitative evaluations, including market drivers, challenges, Porter’s Five Forces, regulatory frameworks, consumer preferences, and ESG (Environmental, Social, and Governance) factors.

The report provides detailed classification of Small Nucleic Acid Drug, such as type, etc.; detailed examples of Small Nucleic Acid Drug applications, such as application one, etc., and provides comprehensive historical (2020-2025) and forecast (2026-2031) market size data.

The report provides detailed classification of Small Nucleic Acid Drug, such as Antisense Oligonucleotides (ASO), siRNA, Other, etc.; detailed examples of Small Nucleic Acid Drug applications, such as Neuromuscular Diseases, hATTR, Other, etc., and provides comprehensive historical (2020-2025) and forecast (2026-2031) market size data.

The report covers key global regions—North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa—providing granular, country-specific insights for major markets such as the United States, China, Germany, and Brazil.

The report deeply explores the competitive landscape of Small Nucleic Acid Drug products, details the sales, revenue, and regional layout of some of the world's leading manufacturers, and provides in-depth company profiles and contact details.

The report contains a comprehensive industry chain analysis covering raw materials, downstream customers and sales channels.

Core Chapters

Chapter One: Introduces the study scope of this report, market status, market drivers, challenges, porters five forces analysis, regulatory policy, consumer preference, market attractiveness and ESG analysis.

Chapter Two: market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Small Nucleic Acid Drug market sales and revenue in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter Four: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Five: Detailed analysis of Small Nucleic Acid Drug manufacturers competitive landscape, price, sales, revenue, market share, footprint, merger, and acquisition information, etc.

Chapter Six: Provides profiles of leading manufacturers, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction.

Chapter Seven: Analysis of industrial chain, key raw materials, customers and sales channel.

Chapter Eight: Key Takeaways and Final Conclusions

Chapter Nine: Methodology and Sources.

1 Small Nucleic Acid Drug Market Overview and Qualitative Analysis
1.1 Small Nucleic Acid Drug Product Definition and Statistical Scope
1.2 Small Nucleic Acid Drug Market Status and Outlook
1.2.1 Small Nucleic Acid Drug Market Revenue Estimates and Forecasts 2020-2031
1.2.2 Small Nucleic Acid Drug Market Sales Estimates and Forecasts 2020-2031
1.3 Small Nucleic Acid Drug Market Driver Analysis
1.4 Small Nucleic Acid Drug Market Challenges Analysis
1.5 Porter's Five Forces Analysis
1.5.1 Bargaining Power of Suppliers
1.5.2 Bargaining Power of Buyers/Consumers
1.5.3 Threat of New Entrants
1.5.4 Threat of Substitute Products
1.5.5 Intensity of Competitive Rivalry
1.6 Regulatory Policy Analysis
1.7 Consumer Preference Analysis
1.8 Market Attractiveness Analysis
1.9 ESG (Environmental, Social and Governance) Analysis
2 Small Nucleic Acid Drug Market Type Estimates & Trend Analysis
2.1 Small Nucleic Acid Drug Type Dashboard
2.2 Small Nucleic Acid Drug Market by Type
2.2.1 Antisense Oligonucleotides (ASO)
2.2.2 siRNA
2.2.3 Other
2.3 Global Small Nucleic Acid Drug Market Size by Type
2.3.1 Historical Analysis of the Global Small Nucleic Acid Drug Market Size by Type (2020-2025)
2.3.2 Projected Analysis of Global Small Nucleic Acid Drug Market Size by Type (2026–2031)
3 Small Nucleic Acid Drug Market Geography Estimates & Trend Analysis
3.1 Small Nucleic Acid Drug Geography Dashboard
3.2 Global Small Nucleic Acid Drug Historic Market Size by Region
3.2.1 Global Small Nucleic Acid Drug Market Sales by Region (2020-2025)
3.2.2 Global Small Nucleic Acid Drug Market Revenue by Region (2020-2025)
3.3 Global Small Nucleic Acid Drug Forecasted Market Size by Region
3.3.1 Global Small Nucleic Acid Drug Market Sales by Region (2026-2031)
3.3.2 Global Small Nucleic Acid Drug Market Revenue by Region (2026-2031)
3.4 North America Small Nucleic Acid Drug Market by Country
3.4.1 North America Small Nucleic Acid Drug Market Sales by Country (2020-2031)
3.4.2 North America Small Nucleic Acid Drug Market Revenue by Country (2020-2031)
3.4.3 United States Small Nucleic Acid Drug Market Sales, Revenue and Growth Rate (2020-2031)
3.4.4 Canada Small Nucleic Acid Drug Market Sales, Revenue and Growth Rate (2020-2031)
3.5 Europe Small Nucleic Acid Drug Market by Country
3.5.1 Europe Small Nucleic Acid Drug Market Sale by Country (2020-2031)
3.5.2 Europe Small Nucleic Acid Drug Market Revenue by Country (2020-2031)
3.5.3 Germany Market Sales, Revenue and Growth Rate (2020-2031)
3.5.4 France Market Sales, Revenue and Growth Rate (2020-2031)
3.5.5 U.K. Market Sales, Revenue and Growth Rate (2020-2031)
3.5.6 Italy Market Sales, Revenue and Growth Rate (2020-2031)
3.5.7 Spain Market Sales, Revenue and Growth Rate (2020-2031)
3.6 Asia-Pacific Small Nucleic Acid Drug Market by Region
3.6.1 Asia-Pacific Small Nucleic Acid Drug Market Sales by Region (2020-2031)
3.6.2 Asia-Pacific Small Nucleic Acid Drug Market Revenue by Region (2020-2031)
3.6.3 China Market Sales, Revenue and Growth Rate (2020-2031)
3.6.4 Japan Market Sales, Revenue and Growth Rate (2020-2031)
3.6.5 South Korea Market Sales, Revenue and Growth Rate (2020-2031)
3.6.6 India Market Sales, Revenue and Growth Rate (2020-2031)
3.6.7 Southeast Asia Market Sales, Revenue and Growth Rate (2020-2031)
3.7 Latin America Small Nucleic Acid Drug Market by Country
3.7.1 Latin America Small Nucleic Acid Drug Market Sales by Country (2020-2031)
3.7.2 Latin America Small Nucleic Acid Drug Market Revenue by Country (2020-2031)
3.7.3 Mexico Market Sales, Revenue and Growth Rate (2020-2031)
3.7.4 Brazil Market Sales, Revenue and Growth Rate (2020-2031)
3.8 Middle East and Africa Small Nucleic Acid Drug Market by Country
3.8.1 Middle East and Africa Small Nucleic Acid Drug Market Sales by Country (2020-2031)
3.8.2 Middle East and Africa Small Nucleic Acid Drug Market Revenue by Country (2020-2031)
3.8.3 Turkey Market Sales, Revenue and Growth Rate (2020-2031)
3.8.4 Saudi Arabia Market Sales, Revenue and Growth Rate (2020-2031)
3.8.5 South Africa Market Sales, Revenue and Growth Rate (2020-2031)
4 Small Nucleic Acid Drug Market Application Estimates & Trend Analysis
4.1 Small Nucleic Acid Drug Market Application Dashboard
4.2 Small Nucleic Acid Drug Market by Application
4.2.1 Neuromuscular Diseases
4.2.2 hATTR
4.2.3 Other
4.3 Global Small Nucleic Acid Drug Market Size by Application
4.3.1 Historical Analysis of Global Small Nucleic Acid Drug Market Size by Application (2020-2025)
4.3.2 Projected Analysis of Global Small Nucleic Acid Drug Market Size by Application (2026-2031)
5 Small Nucleic Acid Drug Market Competitive Landscape Analysis
5.1 Global Small Nucleic Acid Drug Leading Manufacturers’ Market Sales Performance and Share Analysis
5.2 Global Small Nucleic Acid Drug Leading Manufacturers’ Market Revenue Performance and Share Analysis
5.3 Global Small Nucleic Acid Drug Leading Manufacturers’ Average Sales Price (2020-2025)
5.4 Global Small Nucleic Acid Drug Leading Manufacturers’ Regional Footprint (Headquarters, Manufacturing Base and Sales Ares)
5.5 Mergers and Acquisition Analysis
6 Leading Manufacturers’ Company Profiles
6.1 Sarepta Therapeutics
6.1.1 Sarepta Therapeutics Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.1.2 Sarepta Therapeutics Introduction and Business Overview
6.1.3 Sarepta Therapeutics Small Nucleic Acid Drug Product Portfolio
6.1.4 Sarepta Therapeutics Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.2 Ionis Pharmaceuticals
6.2.1 Ionis Pharmaceuticals Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.2.2 Ionis Pharmaceuticals Introduction and Business Overview
6.2.3 Ionis Pharmaceuticals Small Nucleic Acid Drug Product Portfolio
6.2.4 Ionis Pharmaceuticals Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.3 Alnylam
6.3.1 Alnylam Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.3.2 Alnylam Introduction and Business Overview
6.3.3 Alnylam Small Nucleic Acid Drug Product Portfolio
6.3.4 Alnylam Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.4 Biogen
6.4.1 Biogen Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.4.2 Biogen Introduction and Business Overview
6.4.3 Biogen Small Nucleic Acid Drug Product Portfolio
6.4.4 Biogen Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.5 Nippon Shinyaku
6.5.1 Nippon Shinyaku Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.5.2 Nippon Shinyaku Introduction and Business Overview
6.5.3 Nippon Shinyaku Small Nucleic Acid Drug Product Portfolio
6.5.4 Nippon Shinyaku Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.6 Sobi
6.6.1 Sobi Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.6.2 Sobi Introduction and Business Overview
6.6.3 Sobi Small Nucleic Acid Drug Product Portfolio
6.6.4 Sobi Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.7 Novartis
6.7.1 Novartis Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.7.2 Novartis Introduction and Business Overview
6.7.3 Novartis Small Nucleic Acid Drug Product Portfolio
6.7.4 Novartis Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.8 Jazz Pharmaceuticals
6.8.1 Jazz Pharmaceuticals Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.8.2 Jazz Pharmaceuticals Introduction and Business Overview
6.8.3 Jazz Pharmaceuticals Small Nucleic Acid Drug Product Portfolio
6.8.4 Jazz Pharmaceuticals Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.9 AstraZeneca
6.9.1 AstraZeneca Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.9.2 AstraZeneca Introduction and Business Overview
6.9.3 AstraZeneca Small Nucleic Acid Drug Product Portfolio
6.9.4 AstraZeneca Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.10 Novo Nordisk
6.10.1 Novo Nordisk Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.10.2 Novo Nordisk Introduction and Business Overview
6.10.3 Novo Nordisk Small Nucleic Acid Drug Product Portfolio
6.10.4 Novo Nordisk Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.11 Astellas Pharma
6.11.1 Astellas Pharma Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.11.2 Astellas Pharma Introduction and Business Overview
6.11.3 Astellas Pharma Small Nucleic Acid Drug Product Portfolio
6.11.4 Astellas Pharma Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.12 Geron Corporation
6.12.1 Geron Corporation Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.12.2 Geron Corporation Introduction and Business Overview
6.12.3 Geron Corporation Small Nucleic Acid Drug Product Portfolio
6.12.4 Geron Corporation Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.13 CureVac
6.13.1 CureVac Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.13.2 CureVac Introduction and Business Overview
6.13.3 CureVac Small Nucleic Acid Drug Product Portfolio
6.13.4 CureVac Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.14 Regulus Therapeutics
6.14.1 Regulus Therapeutics Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.14.2 Regulus Therapeutics Introduction and Business Overview
6.14.3 Regulus Therapeutics Small Nucleic Acid Drug Product Portfolio
6.14.4 Regulus Therapeutics Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.15 ProQR
6.15.1 ProQR Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.15.2 ProQR Introduction and Business Overview
6.15.3 ProQR Small Nucleic Acid Drug Product Portfolio
6.15.4 ProQR Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.16 Secarna
6.16.1 Secarna Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.16.2 Secarna Introduction and Business Overview
6.16.3 Secarna Small Nucleic Acid Drug Product Portfolio
6.16.4 Secarna Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.17 MiNA Therapeutics
6.17.1 MiNA Therapeutics Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.17.2 MiNA Therapeutics Introduction and Business Overview
6.17.3 MiNA Therapeutics Small Nucleic Acid Drug Product Portfolio
6.17.4 MiNA Therapeutics Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.18 Sylentis
6.18.1 Sylentis Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.18.2 Sylentis Introduction and Business Overview
6.18.3 Sylentis Small Nucleic Acid Drug Product Portfolio
6.18.4 Sylentis Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.19 Arrowhead
6.19.1 Arrowhead Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.19.2 Arrowhead Introduction and Business Overview
6.19.3 Arrowhead Small Nucleic Acid Drug Product Portfolio
6.19.4 Arrowhead Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
6.20 Silence Therapeutics
6.20.1 Silence Therapeutics Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
6.20.2 Silence Therapeutics Introduction and Business Overview
6.20.3 Silence Therapeutics Small Nucleic Acid Drug Product Portfolio
6.20.4 Silence Therapeutics Small Nucleic Acid Drug Market Performance Analysis (Revenue, Sales, Price, Gross Margin and Market Share)
7 Industry Chain Analysis
7.1 Upstream Key Raw Materials
7.1.1 Raw Materials A Definition and Suppliers
7.1.2 Raw Materials B Definition and Suppliers
7.1.3 Raw Materials C Definition and Suppliers
7.2 Small Nucleic Acid Drug Typical Downstream Customers
7.3 Small Nucleic Acid Drug Sales Channel Analysis
8 Key Takeaways and Final Conclusions
9 Methodology and Sources
9.1 Research Methodology
9.2 Data Mining
9.2.1 Preliminary Data Sources
9.2.2 Secondary Sources
9.3 Industry Analysis Matrix
9.4 Disclaimer

Table 1. Small Nucleic Acid Drug Market Driver Analysis
Table 2. Small Nucleic Acid Drug Market Challenges Analysis
Table 3. Small Nucleic Acid Drug Regulatory Policy Analysis
Table 4. Small Nucleic Acid Drug Consumer Preference Analysis
Table 5. Small Nucleic Acid Drug Market Attractiveness Analysis
Table 6. Small Nucleic Acid Drug ESG Analysis
Table 7. Global Small Nucleic Acid Drug Market Revenue by Type: 2020 VS 2024 VS 2031
Table 8. Global Small Nucleic Acid Drug Market Sales by Type (2020-2025)
Table 9. Global Small Nucleic Acid Drug Market Sales Share by Type (2020-2025)
Table 10. Global Small Nucleic Acid Drug Market Revenue by Type (2020-2025)
Table 11. Global Small Nucleic Acid Drug Market Revenue Share by Type (2020-2025)
Table 12. Global Small Nucleic Acid Drug Market Price by Type (2020-2025)
Table 13. Global Small Nucleic Acid Drug Market Sales by Type (2026-2031)
Table 14. Global Small Nucleic Acid Drug Market Sales Share by Type (2026-2031)
Table 15. Global Small Nucleic Acid Drug Market Revenue by Type (2026-2031)
Table 16. Global Small Nucleic Acid Drug Market Revenue Share by Type (2026-2031)
Table 17. Global Small Nucleic Acid Drug Market Price by Type (2026-2031)
Table 18. Global Small Nucleic Acid Drug Market Size Comparison by Region: 2020 VS 2024 VS 2031
Table 19. Global Small Nucleic Acid Drug Market Sales by Region (2020-2025)
Table 20. Global Small Nucleic Acid Drug Market Sales Share by Region (2020-2025)
Table 21. Global Small Nucleic Acid Drug Market Revenue by Region (2020-2025)
Table 22. Global Small Nucleic Acid Drug Market Revenue Share by Region (2020-2025)
Table 23. Global Small Nucleic Acid Drug Market Sales by Region (2026-2031)
Table 24. Global Small Nucleic Acid Drug Market Sales Share in Volume by Region (2026-2031)
Table 25. Global Small Nucleic Acid Drug Market Revenue by Region (2026-2031)
Table 26. Global Small Nucleic Acid Drug Market Revenue Share by Region (2026-2031)
Table 27. North America Small Nucleic Acid Drug Market Sales by Country (2020-2025)
Table 28. North America Small Nucleic Acid Drug Market Sales by Country (2026-2031)
Table 29. North America Small Nucleic Acid Drug Market Revenue by Country (2020-2025)
Table 30. North America Small Nucleic Acid Drug Market Revenue by Country (2026-2031)
Table 31. Europe Small Nucleic Acid Drug Market Sales by Country (2020-2025)
Table 32. Europe Small Nucleic Acid Drug Market Sales by Country (2026-2031)
Table 33. Europe Small Nucleic Acid Drug Market Revenue by Country (2020-2025)
Table 34. Europe Small Nucleic Acid Drug Market Revenue by Country (2026-2031)
Table 35. Asia-Pacific Small Nucleic Acid Drug Market Sales by Region (2020-2025)
Table 36. Asia-Pacific Small Nucleic Acid Drug Market Sales by Region (2026-2031)
Table 37. Asia-Pacific Small Nucleic Acid Drug Market Revenue by Region (2020-2025)
Table 38. Asia-Pacific Small Nucleic Acid Drug Market Revenue by Region (2026-2031)
Table 39. Latin America Small Nucleic Acid Drug Market Sales by Country (2020-2025)
Table 40. Latin America Small Nucleic Acid Drug Market Sales by Country (2026-2031)
Table 41. Latin America Small Nucleic Acid Drug Market Revenue by Country (2020-2025)
Table 42. Latin America Small Nucleic Acid Drug Market Revenue by Country (2026-2031)
Table 43. Middle East and Africa Small Nucleic Acid Drug Market Sales by Country (2020-2025)
Table 44. Middle East and Africa Small Nucleic Acid Drug Market Sales by Country (2026-2031)
Table 45. Middle East and Africa Small Nucleic Acid Drug Market Revenue by Country (2020-2025)
Table 46. Middle East and Africa Small Nucleic Acid Drug Market Revenue by Country (2026-2031)
Table 47. Global Small Nucleic Acid Drug Market Revenue by Application: 2020 VS 2024 VS 2031
Table 48. Global Small Nucleic Acid Drug Market Sales by Application (2020-2025)
Table 49. Global Small Nucleic Acid Drug Market Sales Share by Application (2020-2025)
Table 50. Global Small Nucleic Acid Drug Market Revenue by Application (2020-2025)
Table 51. Global Small Nucleic Acid Drug Market Revenue Share by Application (2020-2025)
Table 52. Global Small Nucleic Acid Drug Market Price by Application (2020-2025)
Table 53. Global Small Nucleic Acid Drug Market Sales by Application (2026-2031)
Table 54. Global Small Nucleic Acid Drug Market Sales Share by Application (2026-2031)
Table 55. Global Small Nucleic Acid Drug Market Revenue by Application (2026-2031)
Table 56. Global Small Nucleic Acid Drug Market Revenue Share by Application (2026-2031)
Table 57. Global Small Nucleic Acid Drug Market Price by Application (2026-2031)
Table 58. Global Small Nucleic Acid Drug Leading Manufacturers’ Market Sales Performance
Table 59. Global Small Nucleic Acid Drug Leading Manufacturers’ Market Sales Share
Table 60. Global Small Nucleic Acid Drug Leading Manufacturers’ Market Revenue Performance (2020-2025)
Table 61. Global Small Nucleic Acid Drug Leading Manufacturers’ Market Revenue Share (2020-2025)
Table 62. Global Small Nucleic Acid Drug Leading Manufacturers’ Average Sales Price (2020-2025)
Table 63. Global Small Nucleic Acid Drug Leading Manufacturers’ Regional Footprint (Headquarters, Manufacturing Base and Sales Areas)
Table 64. Mergers and Acquisition Analysis
Table 65. Sarepta Therapeutics Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 66. Sarepta Therapeutics Introduction and Business Overview
Table 67. Sarepta Therapeutics Small Nucleic Acid Drug Product
Table 68. Sarepta Therapeutics Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 69. Ionis Pharmaceuticals Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 70. Ionis Pharmaceuticals Introduction and Business Overview
Table 71. Ionis Pharmaceuticals Small Nucleic Acid Drug Product
Table 72. Ionis Pharmaceuticals Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 73. Alnylam Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 74. Alnylam Introduction and Business Overview
Table 75. Alnylam Small Nucleic Acid Drug Product
Table 76. Alnylam Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 77. Biogen Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 78. Biogen Introduction and Business Overview
Table 79. Biogen Small Nucleic Acid Drug Product
Table 80. Biogen Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 81. Nippon Shinyaku Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 82. Nippon Shinyaku Introduction and Business Overview
Table 83. Nippon Shinyaku Small Nucleic Acid Drug Product
Table 84. Nippon Shinyaku Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 85. Sobi Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 86. Sobi Introduction and Business Overview
Table 87. Sobi Small Nucleic Acid Drug Product
Table 88. Sobi Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 89. Novartis Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 90. Novartis Introduction and Business Overview
Table 91. Novartis Small Nucleic Acid Drug Product
Table 92. Novartis Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 93. Jazz Pharmaceuticals Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 94. Jazz Pharmaceuticals Introduction and Business Overview
Table 95. Jazz Pharmaceuticals Small Nucleic Acid Drug Product
Table 96. Jazz Pharmaceuticals Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 97. AstraZeneca Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 98. AstraZeneca Introduction and Business Overview
Table 99. AstraZeneca Small Nucleic Acid Drug Product
Table 100. AstraZeneca Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 101. Novo Nordisk Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 102. Novo Nordisk Introduction and Business Overview
Table 103. Novo Nordisk Small Nucleic Acid Drug Product
Table 104. Novo Nordisk Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 105. Astellas Pharma Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 106. Astellas Pharma Introduction and Business Overview
Table 107. Astellas Pharma Small Nucleic Acid Drug Product
Table 108. Astellas Pharma Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 109. Geron Corporation Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 110. Geron Corporation Introduction and Business Overview
Table 111. Geron Corporation Small Nucleic Acid Drug Product
Table 112. Geron Corporation Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 113. CureVac Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 114. CureVac Introduction and Business Overview
Table 115. CureVac Small Nucleic Acid Drug Product
Table 116. CureVac Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 117. Regulus Therapeutics Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 118. Regulus Therapeutics Introduction and Business Overview
Table 119. Regulus Therapeutics Small Nucleic Acid Drug Product
Table 120. Regulus Therapeutics Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 121. ProQR Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 122. ProQR Introduction and Business Overview
Table 123. ProQR Small Nucleic Acid Drug Product
Table 124. ProQR Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 125. Secarna Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 126. Secarna Introduction and Business Overview
Table 127. Secarna Small Nucleic Acid Drug Product
Table 128. Secarna Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 129. MiNA Therapeutics Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 130. MiNA Therapeutics Introduction and Business Overview
Table 131. MiNA Therapeutics Small Nucleic Acid Drug Product
Table 132. MiNA Therapeutics Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 133. Sylentis Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 134. Sylentis Introduction and Business Overview
Table 135. Sylentis Small Nucleic Acid Drug Product
Table 136. Sylentis Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 137. Arrowhead Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 138. Arrowhead Introduction and Business Overview
Table 139. Arrowhead Small Nucleic Acid Drug Product
Table 140. Arrowhead Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 141. Silence Therapeutics Overview (Basic Corporate Information, Manufacturing Footprint, Geographic Sales Presence and Key Competitors)
Table 142. Silence Therapeutics Introduction and Business Overview
Table 143. Silence Therapeutics Small Nucleic Acid Drug Product
Table 144. Silence Therapeutics Small Nucleic Acid Drug Sales, Revenue, Price, Gross Margin and Market Share (2020-2025)
Table 145. Raw Materials A Key Suppliers Lists
Table 146. Raw Materials B Key Suppliers Lists
Table 147. Raw Materials C Key Suppliers Lists
Table 148. Small Nucleic Acid Drug Typical Downstream Customers
Table 149. Research Programs/Design for This Report
Figure 1. Small Nucleic Acid Drug Product Picture
Figure 2. Global Small Nucleic Acid Drug Market Size, 2020 VS 2024 VS 2031
Figure 3. Global Small Nucleic Acid Drug Market Size Status and Outlook (2020-2031)
Figure 4. Global Small Nucleic Acid Drug Sales Status and Outlook (2020-2031)
Figure 5. Small Nucleic Acid Drug Porter's Five Forces Analysis Picture
Figure 6. Global Small Nucleic Acid Drug Market Revenue by Type (2020-2031)
Figure 7. Global Small Nucleic Acid Drug Market Revenue Share by Type in 2024 & 2031
Figure 8. Product Picture of Antisense Oligonucleotides (ASO)
Figure 9. Global Antisense Oligonucleotides (ASO) Revenue and Growth Rate (2020-2031)
Figure 10. Product Picture of siRNA
Figure 11. Global siRNA Revenue and Growth Rate (2020-2031)
Figure 12. Product Picture of Other
Figure 13. Global Other Revenue and Growth Rate (2020-2031)
Figure 14. United States Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 15. United States Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 16. Canada Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 17. Canada Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 18. Germany Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 19. Germany Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 20. France Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 21. France Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 22. U.K. Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 23. U.K. Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 24. Italy Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 25. Italy Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 26. Spain Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 27. Spain Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 28. China Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 29. China Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 30. Japan Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 31. Japan Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 32. South Korea Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 33. South Korea Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 34. India Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 35. India Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 36. Southeast Asia Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 37. Southeast Asia Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 38. Mexico Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 39. Mexico Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 40. Brazil Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 41. Brazil Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 42. Turkey Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 43. Turkey Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 44. Saudi Arabia Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 45. Saudi Arabia Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 46. South Africa Small Nucleic Acid Drug Market Sales and Growth Rate (2020-2031)
Figure 47. South Africa Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2031)
Figure 48. Global Small Nucleic Acid Drug Market Revenue by Application (2020-2031)
Figure 49. Global Small Nucleic Acid Drug Revenue Market Share by Application in 2024 & 2031
Figure 50. Product Picture of Neuromuscular Diseases
Figure 51. Global Neuromuscular Diseases Revenues YoY Growth (2020-2031)
Figure 52. Product Picture of hATTR
Figure 53. Global hATTR Revenues YoY Growth (2020-2031)
Figure 54. Product Picture of Other
Figure 55. Global Other Revenues YoY Growth (2020-2031)
Figure 56. Small Nucleic Acid Drug Channels of Distribution (Direct Vs Distribution)